Mirae Asset Global Investments Co., Ltd. Edgewise Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $30.9 Billion
- Q3 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,073 shares of EWTX stock, worth $92,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,073
Previous 4,062
0.27%
Holding current value
$92,660
Previous $53,000
24.53%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding EWTX
# of Institutions
186Shares Held
112MCall Options Held
188KPut Options Held
121K-
Orbimed Advisors LLC San Diego, CA15.5MShares$353 Million8.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.4MShares$237 Million2.9% of portfolio
-
Baker Bros. Advisors LP New York, NY7.31MShares$166 Million0.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.17MShares$140 Million3.22% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$137 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.44B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...